Theravance Biopharma (TBPH)
NASDAQ:TBPH
Holding TBPH?
Track your performance easily

Theravance Biopharma (TBPH) Income Statement

312 Followers

Theravance Biopharma Income Statement

Last quarter (Q2 2024), Theravance Biopharma's total revenue was $14.26M, an increase of 3.69% from the same quarter last year. In Q2, Theravance Biopharma's net income was $-15.88M. See Theravance Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 62.02M$ 57.42M$ 51.35M$ 55.31M$ 71.86M$ 73.41M
Cost of Revenue
----$ 0.00$ 0.00
Gross Profit
$ 62.02M$ 57.42M$ 51.35M$ 55.31M$ 71.86M$ 73.41M
Operating Expense
$ 103.93M$ 113.46M$ 143.30M$ -313.10M$ 369.61M$ 325.33M
Operating Income
$ -41.91M$ -56.03M$ -91.96M$ -299.70M$ -297.76M$ -251.91M
Net Non Operating Interest Income Expense
$ 5.16M$ -6.77M$ -6.37M$ -8.55M$ -40.14M$ -23.47M
Other Income Expense
$ -3.24M$ -2.39M$ -5.51M$ -1.11M$ 51.36M$ 33.70M
Pretax Income
$ -38.22M$ -49.27M$ -92.81M$ -265.22M$ -286.54M$ -241.68M
Tax Provision
$ 7.43M$ 5.92M$ 9.00K$ -151.00K$ -8.52M$ -5.22M
Earnings From Equity Interest Net Of Tax
---$ 103.99M--
Net Income Common Stockholders
$ -45.01M$ -55.19M$ 832.40M$ -261.49M$ -278.02M$ -236.46M
Basic EPS
$ -1.09$ -1.00$ 23.70$ -2.87$ -4.46$ -4.25
Diluted EPS
$ -1.09$ -1.00$ 23.70$ -2.87$ -4.46$ -4.25
Basic Average Shares
$ 198.63M$ 55.30M$ 73.59M$ 69.46M$ 62.34M$ 55.61M
Diluted Average Shares
$ 198.63M$ 55.30M$ 73.59M$ 69.46M$ 62.34M$ 55.61M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -50.88M$ 111.07M$ 143.30M$ -313.10M$ 369.61M$ 325.33M
Net Income From Continuing And Discontinued Operation
$ -45.65M$ -55.19M$ 872.13M$ -261.49M$ -278.02M$ -236.46M
Normalized Income
$ 359.99M-$ -60.49M-$ -263.01M$ -236.46M
Interest Expense
----$ 44.59M$ 31.86M
EBIT
$ -31.97M$ -46.92M$ -86.45M$ -256.68M$ -241.95M$ -209.81M
EBITDA
$ -22.84M$ -42.66M$ -79.42M$ -248.08M$ -232.89M$ -203.60M
Currency in USD

Theravance Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis